Research and Development Expense of Biopower Operations Corp from 28 Feb 2023 to 31 May 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
Biopower Operations Corp quarterly Research and Development Expense in USD history and change rate from 28 Feb 2023 to 31 May 2023.
  • Biopower Operations Corp Research and Development Expense for the quarter ending 31 May 2023 was $248,773.
Source SEC data
View on sec.gov
Research and Development Expense, Quarterly (USD)

Biopower Operations Corp Quarterly Research and Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $248,773 01 Mar 2023 31 May 2023 10-Q 22 Aug 2023 2023 Q2
Q1 2023 $432,366 01 Dec 2022 28 Feb 2023 10-Q/A 22 Aug 2023 2023 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.